Patent US5518878A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5518878A Expired / Lapsed US ⏱️ 0.0 years remaining

Cryopreservation of cultured skin or cornea equivalents with agitation

Assignee: Organogenesis Inc
•
Filing: 1993-09-15
•
Granted: 1996-05-21
•
Expires: 2013-09-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention is directed to cryopreservation of cultured tissue equivalents made by in vitro technology. The invention involves immersing a cultured tissue equivalent in a cooled cryoprotectant solution, agitating the cryoprotectant solution and the immersed cultured tissue to achieve effective penetration of the cryoprotectant solution into the cultured tissue equivalent, and then freezing the cultured tissue at a high freezing rate. The cryopreserved cultured tissue equivalent may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro.

Inventors

  • 👤 Leon M. Wilkins
  • 👤 Stephen R. Watson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:57
CPC Classifications
A; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/125

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 160 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) serially immersing said cultured skin or cornea equivalent in a series of cryoprotectant solutions which increase in concentration and decrease in temperature to produce a cryoprotected cultured skin or cornea equivalent; (b) cooling said cryoprotected cultured skin or cornea equivalent to a temperature at or below -110° C., at a cooling rate at -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (c) storing said vitrified cultured skin or cornea equivalent at a temperature of -110° C. or below to produce a stored cultured skin or cornea equivalent, wherein one or more members of said series of cryoprotectant solutions of step (a) which increase in concentration and decrease in temperature containing the immersed cultured skin or cornea equivalent is agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent prior to storage.
Claim 2
Independent Claim 160 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) serially immersing said cultured skin or cornea equivalent in a series of cryoprotectant solutions which increase in concentration and decrease in temperature to produce a cryoprotected cultured skin or cornea equivalent; (b) cooling said cryoprotected cultured skin or cornea equivalent to a temperature at or below -110° C., at a cooling rate at -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (c) storing said vitrified cultured skin or cornea equivalent at a temperature of -110° C. or below to produce a stored cultured skin or cornea equivalent, wherein one or more members of said series of cryoprotectant solutions of step (a) which increase in concentration and decrease in temperature containing the immersed cultured skin or cornea equivalent is agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent prior to storage.
Claim 3
Independent Claim 172 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) serially immersing said cultured skin or cornea equivalent in a series of cryoprotectant solutions which increase in concentration and decrease in temperature to produce a cryoprotected cultured skin or cornea equivalent at a final temperature of from -10° C. to -30° C.; (b) cooling said cryoprotected cultured skin or cornea equivalent to a temperature at or below -110° C. at a cooling rate at of -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (c) storing said vitrified cultured skin or cornea equivalent at a temperature of -110° C. or below to produce a stored cultured skin or cornea equivalent, wherein one or more members of said series of cryoprotectant solutions of step (a) which increase in concentration and decrease in temperature containing the immersed cultured skin or cornea equivalent is agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent prior to storage.
Claim 4
Independent Claim 172 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) serially immersing said cultured skin or cornea equivalent in a series of cryoprotectant solutions which increase in concentration and decrease in temperature to produce a cryoprotected cultured skin or cornea equivalent at a final temperature of from -10° C. to -30° C.; (b) cooling said cryoprotected cultured skin or cornea equivalent to a temperature at or below -110° C. at a cooling rate at of -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (c) storing said vitrified cultured skin or cornea equivalent at a temperature of -110° C. or below to produce a stored cultured skin or cornea equivalent, wherein one or more members of said series of cryoprotectant solutions of step (a) which increase in concentration and decrease in temperature containing the immersed cultured skin or cornea equivalent is agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent prior to storage.
Claim 5
Independent Claim 284 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) immersing said cultured skin or cornea equivalent in a first cryoprotectant solution having a concentration of from 15% to 35% cryoprotectant solution in base media at room temperature for a period of time of from 10 to 20 minutes to produce a first cryoprotected cultured skin or cornea equivalent; (b) immersing said first cryoprotected cultured skin or cornea equivalent of step (a) in a second cryoprotectant solution having a concentration of from 40% to 60% cryoprotectant solution in base media at a temperature of from 10° C. to -2° C. for a period of time of from 10 to 20 minutes to produce a second cryoprotected cultured skin or cornea equivalent; (c) finally immersing said second cryoprotected cultured skin or cornea equivalent of step (b) in a third cryoprotectant solution having a concentration of 100% cryoprotectant solution at a temperature of from -10° C. to -30° C. for a period of time of from 10 to 20 minutes to produce a third cryoprotected cultured skin or cornea equivalent; (d) cooling said third cryoprotected cultured skin or cornea equivalent of step (c) to a temperature at or below -110° C. at a cooling rate of -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (e) storing said vitrified cultured skin or cornea equivalent at a temperature at or below -110° C. to produce a stored cultured skin or cornea equivalent, wherein said cultured skin or cornea equivalent of at least step (c) and said cryoprotectant solution are agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent.
Claim 6
Independent Claim 284 words
A method for vitrifying a cultured skin or cornea equivalent, comprising: (a) immersing said cultured skin or cornea equivalent in a first cryoprotectant solution having a concentration of from 15% to 35% cryoprotectant solution in base media at room temperature for a period of time of from 10 to 20 minutes to produce a first cryoprotected cultured skin or cornea equivalent; (b) immersing said first cryoprotected cultured skin or cornea equivalent of step (a) in a second cryoprotectant solution having a concentration of from 40% to 60% cryoprotectant solution in base media at a temperature of from 10° C. to -2° C. for a period of time of from 10 to 20 minutes to produce a second cryoprotected cultured skin or cornea equivalent; (c) finally immersing said second cryoprotected cultured skin or cornea equivalent of step (b) in a third cryoprotectant solution having a concentration of 100% cryoprotectant solution at a temperature of from -10° C. to -30° C. for a period of time of from 10 to 20 minutes to produce a third cryoprotected cultured skin or cornea equivalent; (d) cooling said third cryoprotected cultured skin or cornea equivalent of step (c) to a temperature at or below -110° C. at a cooling rate of -10° C. per minute or faster to produce a vitrified cultured skin or cornea equivalent; and (e) storing said vitrified cultured skin or cornea equivalent at a temperature at or below -110° C. to produce a stored cultured skin or cornea equivalent, wherein said cultured skin or cornea equivalent of at least step (c) and said cryoprotectant solution are agitated under conditions sufficient to achieve effective penetration of said cryoprotectant solution into said cultured skin or cornea equivalent.
Claim 7
Independent Claim 36 words
The method of any one of claims 1, 2 or 3, wherein said cryoprotectant solution comprises one or more agents selected from the group consisting of: a cell-penetrating, glass-forming agent and a non cell-penetrating, glass-forming agent.
Claim 8
Dependent Claim 38 words
The method of claim 4, wherein said non cell-penetrating, glass-forming agent is a high molecular weight form of a complex carbohydrate comprising one or more members selected from the group consisting of: chondroitin sulfate, polyvinylpyrrolidone, and polyethylene glycol.
Claim 9
Dependent Claim 14 words
The method of claim 4, wherein said non cell-penetrating, glass-forming agent is a hetastarch.
Claim 10
Dependent Claim 11 words
The method of claim 6, wherein said herastarch is hydroxyethyl starch.
Claim 11
Dependent Claim 24 words
The method of claim 4, wherein said cell-penetrating, glass-forming agent is selected from the group consisting of: glycerol, propylene glycol, ethylene glycol, and dimethylsulfoxide.
Claim 12
Dependent Claim 12 words
The method of claim 8, wherein said cell-penetrating, glass-forming agent is glycerol.
Claim 13
Independent Claim 32 words
The method of any one of claims 1, 2, or 3, wherein said stored skin or cornea equivalent of step (c) is stored in liquid nitrogen at a temperature of -196° C.
Claim 14
Dependent Claim 78 words
The method of claim 3, wherein said cryoprotectant solution having a concentration of 100% comprises a member selected from the group consisting of: 65% glycerol in Dulbecco's modified Eagles' medium+0.3% newborn calf serum; 20.5% dimethylsulfoxide+15.5% acetamide+10% propylene glycol+6% polyethylene glycol in a base of 0.3% newborn calf serum in Dulbecco's modified Eagles' medium, wherein said cryoprotectant solution having a concentration of 100% is diluted with base media to produce the cryoprotectant solutions of step (a) and step (b).
Claim 15
Independent Claim 31 words
The method of any one of claims 1, 2 or 3, further comprising: thawing said stored cultured tissue equivalent at a rate effective to produce a thawed viable cultured tissue equivalent.
Claim 16
Dependent Claim 23 words
The method of claim 12, further comprising: rinsing said thawed viable cryopreserved cultured tissue equivalent with an isotonic solution buffered at physiological pH.
Claim 17
Dependent Claim 15 words
The method of claim 13, wherein said isotonic solution comprises 0.5 to 2.0 M sucrose.
Claim 18
Independent Claim 26 words
The method of any one of claims 1, 2 or 3, wherein said cooling rate is from -10° C. per minute to -30° C. per minute.
Claim 19
Independent Claim 30 words
The method of any one of claims 1, 2 or 3, wherein said cultured tissue equivalent is sterilely vacuum sealed in a protective pouch prior to said step of cooling.

References Cited (Backward Citations)

US4539716A Cited
US4546500A Cited
US4485096A Cited
US4485097A Cited
US5084377A Cited
US4604346A Cited
US4837379A Cited
US5145770A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-05-21 1999-11-20 2000-05-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-05-21 2003-11-20 2004-05-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-05-21 2007-11-20 2008-05-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag